APAC Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific colorectal cancer diagnostics market is projected to register a substantial CAGR of 9.0% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (China, India, Japan, South Korea, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam and Rest of Asia-Pacific) Industry Trends and Forecast to 2030.

Some of the factors that can affect the growth of the market are:

Initiatives by the government and other authorities for life sciences and funding

Increasing diagnostic products for colorectal cancer

Market Players:

The key market players in Asia-Pacific colorectal cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

Illumina, Inc.

Quest Diagnostics Incorporated

CANON MEDICAL SYSTEMS CORPORATION

Bio-Rad Laboratories, Inc.

Merck KGaA

FUJIFILM Corporation

Agilent Technologies, Inc.

Siemens Healthcare GmbH

Abbott

Neusoft Corporation

BioFire Diagnostics

Myriad Genetics Inc.

QIAGEN

Hologic, Inc.

Time Medical Holding.

PlexBio

GE HealthCare.

1 INTRODUCTION 44

1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.3 OVERVIEW OF THE ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET 44
1.4 LIMITATIONS 46
1.5 MARKETS COVERED 46

2 MARKET SEGMENTATION 49

2.1 MARKETS COVERED 49
2.2 GEOGRAPHICAL SCOPE 50
2.3 YEARS CONSIDERED FOR THE STUDY 51
2.4 CURRENCY AND PRICING 51
2.5 DBMR TRIPOD DATA VALIDATION MODEL 52
2.6 MULTIVARIATE MODELLING 55
2.7 PRODUCT TYPE LIFELINE CURVE 55
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 56
2.9 DBMR MARKET POSITION GRID 57
2.10 MARKET END USER COVERAGE GRID 58
2.11 VENDOR SHARE ANALYSIS 59
2.12 SECONDARY SOURCES 60
2.13 ASSUMPTIONS 60

3 EXECUTIVE SUMMARY 61

4 PREMIUM INSIGHTS 64

4.1 PORTER'S FIVE FORCES 65
4.2 PESTEL ANALYSIS 66

5 INDUSTRY INSIGHTS: 67

6 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 68

6.1 REGULATORY SCENARIO IN THE U.S 68
6.2 REGULATORY SCENARIO IN AUSTRALIA 68
6.3 REGULATORY SCENARIO IN JAPAN 69
6.4 REGULATORY SCENARIO IN CHINA 69

7 MARKET OVERVIEW 71

7.1 DRIVERS 73
- 7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 73
- 7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 73
- 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 73
7.2 RESTRAINTS 74
- 7.2.1 STRINGENT REGULATORY POLICIES 74
- 7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 74
7.3 OPPORTUNITIES 75
- 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 75
- 7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 76
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 76
7.4 CHALLENGES 77
- 7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 77
- 7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 78

8 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 79

8.1 OVERVIEW 80
8.2 INSTRUMENTS 83
- 8.2.1 PATHOLOGY-BASED INSTRUMENTS 84
  - 8.2.1.1 PCR INSTRUMENTS 84
  - 8.2.1.2 SLIDE STAINING SYSTEMS 84
  - 8.2.1.3 TISSUE PROCESSING SYSTEMS 85
  - 8.2.1.4 CELL PROCESSORS 85
  - 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 85
- 8.2.2 IMAGING INSTRUMENTS 85
  - 8.2.2.1 ULTRASOUND SYSTEMS 85
  - 8.2.2.2 CT SYSTEMS 85
  - 8.2.2.3 MRI SYSTEMS 86
  - 8.2.2.4 OTHERS 86
- 8.2.3 BIOPSY INSTRUMENTS 86
- 8.2.4 OTHERS 86
8.3 CONSUMABLES & ACCESSORIES 86
- 8.3.1 KITS 87
  - 8.3.1.1 PCR KITS 87
  - 8.3.1.2 DNA POLYMERASE KITS 87
  - 8.3.1.3 NUCLEIC ACID ISOLATION KITS 87
  - 8.3.1.4 OTHERS 88
- 8.3.2 REAGENTS 88
  - 8.3.2.1 ASSAYS 88
  - 8.3.2.2 BUFFERS 88
  - 8.3.2.3 PRIMERS 88
  - 8.3.2.4 OTHERS 88
- 8.3.3 OTHER CONSUMABLES 88

9 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 89

9.1 OVERVIEW 90
9.2 STOOL EXAMINATION 93
9.3 BLOOD TEST 93
- 9.3.1 COMPLETE BLOOD COUNT (CBC) 94
- 9.3.2 TUMOR MARKER TEST 95
- 9.3.3 LIVER ENZYME BLOOD TEST 95
9.4 IMAGING TEST 95
- 9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 96
- 9.4.2 MRI 96
- 9.4.3 ULTRASOUND 96
- 9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 97
- 9.4.5 OTHERS 97
9.5 TUMOR MARKERS 97
- 9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 98
- 9.5.2 CA19-9 BIOMARKER TEST 98
- 9.5.3 CA 50 MARKER TEST 98
- 9.5.4 OTHERS 98
9.6 BIOPSY 98
9.7 OTHERS 99

10 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 100

10.1 OVERVIEW 101
10.2 STAGE III 104
10.3 STAGE IV 104
10.4 STAGE II 105
10.5 STAGE I 106
10.6 STAGE 0 106

11 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 108

11.1 OVERVIEW 109
11.2 GERIATRIC 112
11.3 ADULTS 112
11.4 PEDIATRIC 113

12 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 115

12.1 OVERVIEW 116
12.2 ADENOCARCINOMA 119
12.3 COLORECTAL LYMPHOMA 119
12.4 GASTROINTESTINAL STROMAL TUMORS 120
12.5 CARCINOID TUMORS 121
12.6 OTHERS 121

13 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 123

13.1 OVERVIEW 124
13.2 HOSPITALS 127
13.3 DIAGNOSTIC CENTERS 127
13.4 CANCER RESEARCH CENTERS 128
13.5 AMBULATORY SURGICAL CENTERS 129
13.6 ACADEMIC INSTITUTES 129
13.7 OTHERS 130

14 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION 132

14.1 ASIA-PACIFIC 133
- 14.1.1 CHINA 143
- 14.1.2 INDIA 148
- 14.1.3 JAPAN 153
- 14.1.4 SOUTH KOREA 158
- 14.1.5 THAILAND 163
- 14.1.6 SINGAPORE 168
- 14.1.7 INDONESIA 173
- 14.1.8 MALAYSIA 178
- 14.1.9 PHILIPPINES 182
- 14.1.10 AUSTRALIA 188
- 14.1.11 VIETNAM 193
- 14.1.12 REST OF ASIA-PACIFIC 198

15 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 199

15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 199

16 SWOT ANALYSIS 200

17 COMPANY PROFILE 201

17.1 F. HOFFMANN- LA ROCHE LTD 201
- 17.1.1 COMPANY SNAPSHOT 201
- 17.1.2 REVENUE ANALYSIS 201
- 17.1.3 COMPANY SHARE ANALYSIS 202
- 17.1.4 PRODUCT PORTFOLIO 202
- 17.1.5 RECENT DEVELOPMENT 202
17.2 KONINKLIJKE PHILIPS N.V. 203
- 17.2.1 COMPANY SNAPSHOT 203
- 17.2.2 REVENUE ANALYSIS 203
- 17.2.3 COMPANY SHARE ANALYSIS 204
- 17.2.4 PRODUCT PORTFOLIO 204
- 17.2.5 RECENT DEVELOPMENT 204
17.3 THERMO FISHER SCIENTIFIC INC. 206
- 17.3.1 COMPANY SNAPSHOT 206
- 17.3.2 REVENUE ANALYSIS 206
- 17.3.3 COMPANY SHARE ANALYSIS 207
- 17.3.4 PRODUCT PORTFOLIO 207
- 17.3.5 RECENT DEVELOPMENT 207
17.4 ILLUMINA, INC. 208
- 17.4.1 COMPANY SNAPSHOT 208
- 17.4.2 REVENUE ANALYSIS 208
- 17.4.3 COMPANY SHARE ANALYSIS 209
- 17.4.4 PRODUCT PORTFOLIO 209
- 17.4.5 RECENT DEVELOPMENT 209
17.5 QUEST DIAGNOSTICS INCORPORATED 210
- 17.5.1 COMPANY SNAPSHOT 210
- 17.5.2 REVENUE ANALYSIS 210
- 17.5.3 COMPANY SHARE ANALYSIS 211
- 17.5.4 PRODUCT PORTFOLIO 211
- 17.5.5 RECENT DEVELOPMENT 211
17.6 ABBOTT 212
- 17.6.1 COMPANY SNAPSHOT 212
- 17.6.2 REVENUE ANALYSIS 212
- 17.6.3 PRODUCT PORTFOLIO 213
- 17.6.4 RECENT DEVELOPMENT 213
17.7 AGILENT TECHNOLOGIES, INC. 214
- 17.7.1 COMPANY SNAPSHOT 214
- 17.7.2 REVENUE ANALYSIS 214
- 17.7.3 PRODUCT PORTFOLIO 215
- 17.7.4 RECENT DEVELOPMENT 215
17.8 BD 216
- 17.8.1 COMPANY SNAPSHOT 216
- 17.8.2 REVENUE ANALYSIS 216
- 17.8.3 PRODUCT PORTFOLIO 217
- 17.8.4 RECENT DEVELOPMENT 217
17.9 BEIJING O&D BIOTECH CO., LTD. 218
- 17.9.1 COMPANY SNAPSHOT 218
- 17.9.2 PRODUCT PORTFOLIO 218
- 17.9.3 RECENT DEVELOPMENT 218
17.10 BIOFIRE DIAGNOSTICS 219
- 17.10.1 COMPANY SNAPSHOT 219
- 17.10.2 REVENUE ANALYSIS 219
- 17.10.3 PRODUCT PORTFOLIO 220
- 17.10.4 RECENT DEVELOPMENT 220
17.11 BIO-RAD LABORATORIES, INC. 221
- 17.11.1 COMPANY SNAPSHOT 221
- 17.11.2 REVENUE ANALYSIS 221
- 17.11.3 PRODUCT PORTFOLIO 222
- 17.11.4 RECENT DEVELOPMENT 222
17.12 CANON MEDICAL SYSTEMS CORPORATION. 223
- 17.12.1 COMPANY SNAPSHOT 223
- 17.12.2 REVENUE ANALYSIS 223
- 17.12.3 PRODUCT PORTFOLIO 224
- 17.12.4 RECENT DEVELOPMENT 224
17.13 FONAR CORP. 225
- 17.13.1 COMPANY SNAPSHOT 225
- 17.13.2 REVENUE ANALYSIS 225
- 17.13.3 PRODUCT PORTFOLIO 226
- 17.13.4 RECENT DEVELOPMENT 226
17.14 FUJIFILM CORPORATION 227
- 17.14.1 COMPANY SNAPSHOT 227
- 17.14.2 REVENUE ANALYSIS 227
- 17.14.3 PRODUCT PORTFOLIO 228
- 17.14.4 RECENT DEVELOPMENT 228
17.15 GE HEALTHCARE. 229
- 17.15.1 COMPANY SNAPSHOT 229
- 17.15.2 REVENUE ANALYSIS 229
- 17.15.3 PRODUCT PORTFOLIO 230
- 17.15.4 RECENT DEVELOPMENT 230
17.16 HOLOGIC, INC. 231
- 17.16.1 COMPANY SNAPSHOT 231
- 17.16.2 REVENUE ANALYSIS 231
- 17.16.3 PRODUCT PORTFOLIO 232
- 17.16.4 RECENT DEVELOPMENT 232
17.17 MEDONICA CO. LTD 233
- 17.17.1 COMPANY SNAPSHOT 233
- 17.17.2 PRODUCT PORTFOLIO 233
- 17.17.3 RECENT DEVELOPMENT 233
17.18 MERCK KGAA 234
- 17.18.1 COMPANY SNAPSHOT 234
- 17.18.2 REVENUE ANALYSIS 234
- 17.18.3 PRODUCT PORTFOLIO 235
- 17.18.4 RECENT DEVELOPMENT 235
17.19 MINFOUND MEDICAL SYSTEMS CO., LTD 236
- 17.19.1 COMPANY SNAPSHOT 236
- 17.19.2 PRODUCT PORTFOLIO 236
- 17.19.3 RECENT DEVELOPMENT 236
17.20 MYRIAD GENETICS, INC. 237
- 17.20.1 COMPANY SNAPSHOT 237
- 17.20.2 REVENUE ANALYSIS 237
- 17.20.3 PRODUCT PORTFOLIO 238
- 17.20.4 RECENT DEVELOPMENT 238
17.21 NEUSOFT CORPORATION 239
- 17.21.1 COMPANY SNAPSHOT 239
- 17.21.2 REVENUE ANALYSIS 239
- 17.21.3 PRODUCT PORTFOLIO 240
- 17.21.4 RECENT DEVELOPMENT 240
17.22 PLEXBIO 241
- 17.22.1 COMPANY SNAPSHOT 241
- 17.22.2 PRODUCT PORTFOLIO 241
- 17.22.3 RECENT DEVELOPMENT 241

17.23 QIAGEN 242
- 17.23.1 COMPANY SNAPSHOT 242
- 17.23.2 REVENUE ANALYSIS 242
- 17.23.3 PRODUCT PORTFOLIO 243
- 17.23.4 RECENT DEVELOPMENT 243
17.24 SIEMENS HEALTHCARE GMBH 244
- 17.24.1 COMPANY SNAPSHOT 244
- 17.24.2 REVENUE ANALYSIS 244
- 17.24.3 1.2.3 PRODUCT PORTFOLIO 245
- 17.24.4 RECENT DEVELOPMENT 245
17.25 STERNMED GMBH 246
- 17.25.1 COMPANY SNAPSHOT 246
- 17.25.2 PRODUCT PORTFOLIO 246
- 17.25.3 RECENT DEVELOPMENT 246
17.26 TIME MEDICAL HOLDING. 247
- 17.26.1 COMPANY SNAPSHOT 247
- 17.26.2 PRODUCT PORTFOLIO 247
- 17.26.3 RECENT DEVELOPMENT 247

18 QUESTIONNAIRE 248

19 RELATED REPORTS 251

LIST OF TABLES

TABLE 1 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
TABLE 2 ASIA PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 3 ASIA PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 4 ASIA PACIFIC PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 5 ASIA PACIFIC IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 6 ASIA PACIFIC CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 7 ASIA PACIFIC CONSUMABLES AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 8 ASIA PACIFIC KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 9 ASIA PACIFIC REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 70
TABLE 10 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 74
TABLE 11 ASIA PACIFIC STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 12 ASIA PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 13 ASIA PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
TABLE 14 ASIA PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 15 ASIA PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 78
TABLE 16 ASIA PACIFIC TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 17 ASIA PACIFIC TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 80
TABLE 18 ASIA PACIFIC BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
TABLE 19 ASIA PACIFIC OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
TABLE 20 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 85
TABLE 21 ASIA PACIFIC STAGE III IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 22 ASIA PACIFIC STAGE IV IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 23 ASIA PACIFIC STAGE II IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 24 ASIA PACIFIC STAGE I IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 25 ASIA PACIFIC STAGE 0 IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 26 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 93
TABLE 27 ASIA PACIFIC GERIATRIC IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 28 ASIA PACIFIC ADULTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 29 ASIA PACIFIC PEDIATRIC IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 30 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 100
TABLE 31 ASIA PACIFIC ADENOCARCINOMA IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 32 ASIA PACIFIC COLORECTAL LYMPHOMA IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 ASIA PACIFIC GASTROINTESTINAL STROMAL TUMORS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 34 ASIA PACIFIC CARCINOID TUMORS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 35 ASIA PACIFIC OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 36 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 108
TABLE 37 ASIA PACIFIC HOSPITALS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
TABLE 38 ASIA PACIFIC DIAGNOSTIC CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
TABLE 39 ASIA PACIFIC CANCER RESEARCH CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 40 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 41 ASIA PACIFIC ACADEMIC INSTITUTES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
TABLE 42 ASIA PACIFIC OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 113
TABLE 43 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 119
TABLE 44 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 45 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 46 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 47 ASIA-PACIFIC IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 48 ASIA-PACIFIC CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 49 ASIA-PACIFIC KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 50 ASIA-PACIFIC REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 51 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
TABLE 52 ASIA-PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 53 ASIA-PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 54 ASIA-PACIFIC TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 55 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 123
TABLE 56 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 123
TABLE 57 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 123
TABLE 58 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 124
TABLE 59 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 60 CHINA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 61 CHINA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 62 CHINA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 63 CHINA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 64 CHINA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 65 CHINA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 66 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 67 CHINA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 68 CHINA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 69 CHINA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 70 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 128
TABLE 71 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 128
TABLE 72 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 129
TABLE 73 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 129
TABLE 74 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 75 INDIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 76 INDIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 77 INDIA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 78 INDIA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 79 INDIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 80 INDIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 81 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 82 INDIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 83 INDIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 84 INDIA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 85 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 133
TABLE 86 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 134
TABLE 87 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 134
TABLE 88 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 134
TABLE 89 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 90 JAPAN INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 91 JAPAN PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 92 JAPAN IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 93 JAPAN CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 94 JAPAN KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 95 JAPAN REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 96 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 97 JAPAN BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 98 JAPAN IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 99 JAPAN TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 100 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 138
TABLE 101 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 139
TABLE 102 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 139
TABLE 103 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 139
TABLE 104 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 105 SOUTH KOREA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 106 SOUTH KOREA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 107 SOUTH KOREA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 108 SOUTH KOREA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 109 SOUTH KOREA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 110 SOUTH KOREA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 111 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 112 SOUTH KOREA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 113 SOUTH KOREA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 114 SOUTH KOREA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 115 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 143
TABLE 116 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 144
TABLE 117 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 144
TABLE 118 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 144
TABLE 119 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 120 THAILAND INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 121 THAILAND PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 122 THAILAND IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 123 THAILAND CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 124 THAILAND KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 125 THAILAND REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 126 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
TABLE 127 THAILAND BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
TABLE 128 THAILAND IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
TABLE 129 THAILAND TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
TABLE 130 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 148
TABLE 131 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 149
TABLE 132 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 149
TABLE 133 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 149
TABLE 134 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 135 SINGAPORE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 136 SINGAPORE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 137 SINGAPORE IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 138 SINGAPORE CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 139 SINGAPORE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 140 SINGAPORE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
TABLE 141 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
TABLE 142 SINGAPORE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
TABLE 143 SINGAPORE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 153
TABLE 144 SINGAPORE TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 153
TABLE 145 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 153
TABLE 146 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 154
TABLE 147 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 154
TABLE 148 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 154
TABLE 149 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 150 INDONESIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 151 INDONESIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 152 INDONESIA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 153 INDONESIA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 154 INDONESIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 155 INDONESIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 156 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 157 INDONESIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 158 INDONESIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 159 INDONESIA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 158
TABLE 160 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 158
TABLE 161 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 158
TABLE 162 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 158
TABLE 163 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 159
TABLE 164 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 165 MALAYSIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 29
FIGURE 2 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 32
FIGURE 3 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 33
FIGURE 4 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 34
FIGURE 5 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 34
FIGURE 6 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 36
FIGURE 7 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 37
FIGURE 8 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 38
FIGURE 9 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 39
FIGURE 10 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 43
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT COLORECTAL CANCER IS EXPECTED TO DRIVE THE ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 44
FIGURE 12 THE INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET IN 2023 & 2030 44
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET 52
FIGURE 14 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 60
FIGURE 15 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 61
FIGURE 16 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 61
FIGURE 17 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 62
FIGURE 18 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 70
FIGURE 19 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 71
FIGURE 20 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 71
FIGURE 21 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 72
FIGURE 22 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022 81
FIGURE 23 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD MILLION) 82
FIGURE 24 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030) 82
FIGURE 25 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE 83
FIGURE 26 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 89
FIGURE 27 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 90
FIGURE 28 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 90
FIGURE 29 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 91
FIGURE 30 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 96
FIGURE 31 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 97
FIGURE 32 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 97
FIGURE 33 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 98
FIGURE 34 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2022 104
FIGURE 35 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 105
FIGURE 36 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 105
FIGURE 37 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 106
FIGURE 38 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 114
FIGURE 39 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 115
FIGURE 40 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 115
FIGURE 41 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 116
FIGURE 42 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 116
FIGURE 43 ASIA PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 179